Clinical Trials Browser

Phase 2 × Recurrence × relmacabtagene autoleucel × Clear all

NCT06479356 2024-08-21

CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

Phase 2 Recruiting

Lymphoma, Non-Hodgkin, Recurrence